Vision Mission & Strength
R & D
Niprolac Oral Sol
Starcal D Forte
Japan Bangladesh joint venture company- NIPRO JMI Pharma held its annual sales conference 2018 at International Convention City, Bashundhara, Dhaka.....
Md. Mizanur Rahman, Chief Executive Officer (CEO) of NIPRO JMI Pharma Limited, has received a prestigious award as the best pharmaceutical professional in Bangladesh-2018.
Nixon contains Ceftriaxone which is a 3rd generation broad-spectrum parenteral cephalosporin antibiotic. It has potent bactericidal activity against a wide range of Gram-positive and Gram-negative organisms. Like other cephalosporins and penicillins, Nixon kills bacteria by interfering with the synthesis of the bacterial cell wall. Nixon has a high degree of stability in the presence of beta lactamases. A remarkable feature of Nixon is its relatively long plasma elimination half-life of about 6 to 9 hours, which makes single or once-daily dosage of the drug appropriate for most patients. Nixon is not metabolized in the body. About 40-65% of a dose of Nixon is excreted unchanged in the urine; the remainder is excreted in the bile and ultimately found in the feces as unchanged drug and microbiologically inactive compound. The drug is highly protein bound (95%).